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license (http://creative(AD). Targeted replacement mice that express either APOE ε4 or its AD benign isoform, APOE
ε3, are used extensively in behavioral, biochemical, and physiological studies directed at assessing
the phenotypic effects of APOE ε4 and at unraveling the mechanisms underlying them. Such exper-
iments often involve pursuing biochemical and behavioral measurements on the same cohort of mice.
In view of the possible cross-talk interactions between brain parameters and cognitive performance,
we presently investigated the extent to which the phenotypic expression of APOE ε4 and APOE ε4 in
targeted replacement mice is affected by behavioral testing. This was performed using young, na€ıve
APOE ε4 and APOE ε3mice in which the levels of distinct brain parameters are affected by the APOE
genotype (e.g., elevated levels of amyloid beta [Ab] and hyperphosphorylated tau and reduced levels
of vesicular glutamate transporter (VGLUT) in hippocampal neurons of APOE ε4 mice). These mice
were exposed to a fear-conditioning paradigm, and the resulting effects on the brain parameters were
examined. The results obtained revealed that the levels of Ab, hyperphosphorylated tau, VGluT, and
doublecortin of the APOE ε4 and APOE ε3 mice were markedly affected following the exposure of
APOE ε4 and APOE ε3 mice to the fear-conditioning paradigm such that the isoform-specific effects
of APOE ε4 on these parameters were greatly diminished.
The finding that behavioral testing affects the APOE ε3 and APOE ε4 phenotypes and masks the
differences between them has important theoretical and practical implications and suggests that the
assessment of brain and behavioral parameters should be performed using different cohorts.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Keywords: Alzheimer’s disease; Apolipoprotein E4 (APOE ε4); Behavior; Fear conditioning; Learning; Synapses; Targetedreplacement mice1. Introduction
Alzheimer’s disease (AD), the most prevalent form of
dementia in the elderly, is characterized by the occurrence
of brain senile plaques and neurofibrillary tangles and by
the loss of brain synapses and neurons, which are associ-




he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).revealed the allelic segregation of the apolipoprotein E
(APOE) gene to families with a higher risk of late-onset
AD and of sporadic AD [4–6]. There are three major
alleles of APOE, termed ε4 (APOE ε4), which are risk
factors for AD, ε3 (APOE ε3), and ε2 (APOE ε2). The
frequency of the apoE4 allele in healthy humans is
w25%, whereas in sporadic AD it is greater than 50%,
and APOE ε4 increases the risk for AD by lowering the
age of onset of the disease by 7 to 9 years per allele
copy [5]. Pathologically, APOE ε4 is associated with
elevated intracellular levels of amyloid beta (Ab) [7,8],imer’s Association. This is an open access article under the CC BY-NC-ND
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synaptic pathology and impaired neuronal plasticity
[11,12]. Declining memory and brain pathology have
been reported in middle-aged APOE ε4 carriers with an
ongoing normal clinical status [13,14], suggesting that
the pathological effects of apoE4 begin decades before
the onset of AD.
APOE ε4-and apoE-targeted replacement mice are used
extensively as a model for investigating the pathological
effects of APOE ε4. Accordingly, behavioral experiments re-
vealed that young apoE4 mice display impairments in object
recognition [15–17], and in contextual fear conditioning
[16,18,19], and in their performance in the Morris water
maze [16,20–22]. Furthermore, these behavioral
impairments were associated with the accumulation of Ab
and hyperphosphorylated tau and with reduced levels of
the presynaptic glutamatergic marker VGluT in
hippocampal neurons of na€ıve APOE ε4 mice [20,23].
Behavioral studies showing no genotype differences or
enhanced performance of APOE ε4 mice have also been
reported [24,25], suggesting that the cognitive
performance of the APOE ε4 mice can be affected by
several additional parameters such as stress and
experimental design.
Previous findings have shown that the exposure of APOE
ε4 and APOE ε3 mice to environmental enrichment (EE) has
differential effects on APOE ε3 and APOE ε4 mice [26,27].
Accordingly, EE triggers synaptogenesis and neurogenesis
in the APOE ε3 mice, whereas in the corresponding apoE4
mice it triggers apoptosis [27]. This provides a proof of prin-
ciple that the APOE phenotype and the differences between
theAPOE ε4 and APOE ε4mice can bemodulated by behav-
ioral manipulation. In the present study we wanted to
examine whether shorter learning and memory-related
behavioral treatments, to which the APOE mice are often
subjected, can affect the phenotypic expression of APOE.
Accordingly, young na€ıve APOE ε4 and APOE ε3 mice
were exposed to a fear-conditioning paradigm or to the cor-
responding sham treatment, whereas a different cohort of
mice was subjected to the novel object recognition para-
digm. The extent to which this affected the accumulation
of the AD hallmarks, Ab and hyperphosphorylated tau,
and the levels of VGluT and doublecortin (DCX) in hippo-
campal neurons was determined. It is instrumental to deter-
mine whether behavioral testing can affect brain and
subsequent physiological parameters factors, as if so, behav-
ioral and biochemical experiments should be performed on
different cohorts of mice.2. Materials and methods
2.1. Mice
APOE-targeted replacement mice, in which the endoge-
nous mouse APOE was replaced by either human APOE
ε3 or APOE ε4, were created by gene targeting [28], andwere purchased from Taconic (Germantown, NY). Mice
were back-crossed to wild-type C57BL/6J mice (Harlan
2BL/610) for 10 generations and were homozygous for the
APOE ε3 (3/3) or APOE ε4 (4/4) alleles. These mice are
referred to in the text as APOE ε3 and APOE ε4 mice,
respectively. The APOE genotype of the micewas confirmed
by PCR analysis, as described previously [26,29]. It should
be noted that the Harlan C57BL/6J mice lack Synuclein.
All the experiments were performed on a 4-month-old
male mice, and were approved by the Tel-Aviv University
Animal Care Committee.2.2. Fear-conditioning test
This test, which assesses emotion-associated and contex-
tual learning [18,30,31], was performed as described in ref.
[16]. Accordingly, on day 1, the mice were placed in a con-
ditioning chamber (context A with light and a metal grid
floor) for 300 seconds during which, they were subjected
to a 2.9 kHz tone, applied for 30 seconds at 80 dB (condi-
tioned stimuli or CS) followed by a single electrical shock
of 1 mA (unconditioned stimuli or US). On day 2, the
mice were placed in a different chamber (context B, which
had no contextual cues) and were subjected to two
20-second tones separated by a 40-second interval. On day
3 the mice were placed in the original conditioning chamber
(context A) and kept there for 300 seconds without being
subjected to either the tone or the foot shock. The mice
were euthanized on day 5. The freezing behavior of the
mice, which is an indication of fear memory, was recorded
and analyzed using the FreezFrame 3.0 video tracking soft-
ware system and the FreezView software system
[19,30,32,33]. Sham-treated mice were subjected to the
same chambers and duration as the fear-conditioned mice
but were not subjected to any tone or shock.2.3. Object recognition test
This test, which is based on the natural tendency of ro-
dents to investigate a novel object, was performed as previ-
ously described [16]. Accordingly, on day 1, the mice were
first placed in an arena (60! 60 cm, with 50-cm walls) in
the absence of objects for 10 minutes. On day 2, the mice
were subjected to two identical objects (A1A) for 5minutes
Two hours later, the mice’s short-term memory was exam-
ined using one old and one novel object (A 1 B) for 5 mi-
nutes. Twenty-four hours later, the mice were reintroduced
to the arena for 5 minutes with a novel object (B 1 C) to
examine their long-term memory. The time spent near
each object was measured and the results are presented as
the ratio (novel)/(novel 1 familiar), where values higher
than 0.5 are indicative of a preference for the new object,
which indicates that the mouse remembers and differentiates
between the new and the old object. The mice were eutha-
nized 48 hours after being tested in the object recognition
test.
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confocal microscopy
Mice were anesthetized with ketamine and xylazine and
perfused transcardially with phosphate buffer saline. Their
brains were then removed and halved, and each hemisphere
was further processed for either histological or biochemical
analysis, as previously described [20]. In brief, one brain
hemisphere was fixed overnight with 4% paraformaldehyde
in 0.1Mphosphate buffer, pH 7.4, and then placed in 30% su-
crose for 48 h. Frozen coronal sections (30 mm)were then cut
on a slidingmicrotome, collected serially, placed in 200 ml of
cryoprotectant (containing glycerin, ethylene glycol, and
0.1 M sodium-phosphate buffer, pH 7.4), and stored at
220C until use. Free-floating sections were immunostained
with the following primary antibodies (Abs): rabbit anti-
Ab42 (1:500; Chemicon, Temecula, CA); rabbit anti-202/
205 phosphorylated tau (AT8, 1:200, Innogenetics);
guinea-pig anti-VGluT1 (1:2000; Millipore); and goat anti-
DCX (1:200; Santa Cruz). The immunostained sections
were viewed using a Zeiss light microscope (Axioskop,
Oberkochen, Germany) interfaced with a CCD video camera
(Kodak Megaplus, Rochester, NY, USA). Pictures of stained
brains were obtained at!10 magnification. VGluT staining
was performed using immunofluorescence staining. Immu-
nofluorescence was visualized using a confocal scanning
lasermicroscope (Zeiss, LSM510). Images (!20magnifica-
tion 1024! 1024 pixels, 12 bit) were acquired by averaging
eight scans. Analysis and quantification of the staining in
Cornu Ammonis region 3 (CA3) (in which the effects of
the apoE genotype were previously shown to be most pro-
nounced [20]), and in the dentate gyrus (DG) for DCX (neu-
rogenesis in the hippocampus is located in the DG) were
performed using the Image-Pro plus system for image anal-
ysis (v. 5.1, Media Cybernetics, Silver Spring, MD, USA).
The intensities of digital audio broadcasting (DAB) staining
or immunofluorescence staining were expressed as the per-
centage of the area stained, as previously described [34].
All images for each immunostaining were obtained under
identical conditions, and their quantitative analyseswere per-
formed with no further handling. Moderate adjustments for
contrast and brightness were performed evenly on all the pre-
sented images of the different mouse groups.2.5. Immunoblot analysis
Immunoblot analysis was performed as previously
described [35,36]. In brief, one brain hemisphere was
taken; the hippocampus was removed, frozen in liquid
nitrogen, and stored at 270C until use. The dissected
hippocampus samples from each brain were then
homogenized in 200 ml of the following detergent-free ho-
mogenization buffer (10 mM HEPES, 2 mM ethylenediami-
netetraacetic acid (EDTA), 2 mM ethylene glycol tetraacetic
acid (EGTA), 0.5 mM dithiothreitol (DTT), protease inhibi-
tor cocktail [Sigma P8340] and phosphatase inhibitor cock-tail [Sigma P5726]). The homogenates were then liquidated
and stored at 270C. Gel electrophoresis and immunoblot
assays were performed on sodium dodecyl sulfate (SDS)-
treated samples (boiling for 10 min in 0.5% SDS) as previ-
ously described [34,35] using the following antibodies:
goat anti-APOE (1:10,000, Chemicon) and rabbit anti-
ATP-binding cassette transporters A1 (ABCA1, 1:500; No-
vous). Protein concentration was determined using the
BCA protein assay kit (Pierce 23225). The immunoblot
bands were visualized using the ECL substrate (Pierce), after
which their intensity was quantified using EZQuantGel soft-
ware (EZQuant, Tel-Aviv, Israel). GAPDH levels were used
as gel loading controls and the results are presented relative
to the apoE3 mice.3. Results
3.1. Fear-conditioning test
APOE ε4-and APOE ε3-targeted replacement mice were
subjected to a fear-conditioning test in which their freezing
response to a tone (CS) coupled with electrical stimulation
(US) was assessed. Twenty-four hours following stimula-
tion, the mice were assessed by a cue test in which their
freezing in novel cages following exposure to the tone was
determined. This was followed by context testing after 48
hours in which the percentage of the mice that were freezing
was determined following their reintroduction to the cages
where the shock was administered. The APOE ε4 and
APOE ε3 mice displayed negligible freezing before stimula-
tion. However, both mouse groups froze significantly and
equally after exposure to the combined electrical and tone
stimuli (Fig. 1).
A subsequent cue memory experiment revealed that the
APOE ε4 and APOE ε3 mice froze similarly following expo-
sure to tone in a new environment, whereas in the subsequent
context test the APOE ε4 mice froze significantly less than
did theAPOE ε3micewhen theywere returned to the original
chamber with no further stimulation (Fig. 1). Control sham
treatment, inwhich bothmouse groupswere similarly treated
except that no stimulus was given, resulted in an insignificant
freezing response during all stages of the paradigm (Fig. 1C).
Taken together, these results indicate that APOE ε4 impairs
contextual memory but not cue-driven memory. The contex-
tual memory is hippocampus dependent, whereas the cue test
is related to the amygdala [18]. These results are thus in
accordance with our previous findings that APOE ε4 induces
distinct hippocampal impairment [16].
3.2. The effect of fear-conditioning testing on brain
parameters3.2.1. APOE and the lipidation protein ABCA1
Immunoblot measurements of the levels of these proteins
in the hippocampi of APOE ε4 and APOE ε3 mice revealed,
in accordance with previous publications [20,23], lower
Fig. 1. Fear conditioning test. Apolipoprotein (APOE ε3) andAPOE ε4micewere subjected to a coupled fear conditioning test (tone as the conditional stimulus,
followed by electrical stimulation as the unconditional stimulus), or sham treated as described in section 2. (A) The paradigm. On day 1 the mice received the
electrical and tone stimulation, on day 2 they were exposed to the sound in a different chamber, whereas on day 3 they were exposed to the original conditioning
chamber without any stimulation. (B) The fear conditioning test. The results presented (mean 6 SEM; n 5 8–10 per group) correspond to the percentage of
freezing time after stimulation on day 1, following the cue on day 2, and with the contextual test on day 3. They were obtained using the EthoVision comput-
erized system and the FreezeFrame programs described in section 2. **P, .01. (C) Sham treatment. The results presented (mean6 SEM; n5 8–10 per group)
correspond to the percentage of freezing time of the sham-treated mice. Results shown are as in (B) except that the mice were not subjected to the electrical and
tone stimulations.
S. Salomon-Zimri et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (2015) 127-135130levels in APOE ε4 than in the APOE ε3 mice (Fig. 2). Expo-
sure of the mice to the fear-conditioning paradigm abolished
the differences between the APOE ε3 and APOE ε4 mice for
both parameters. In the case of APOE, this was associated
with an elevated level of APOE ε4, rendering it equal to
APOE ε3, whereas in the case of ABCA1, the fear-
conditioning paradigm was associated with a specific reduc-
tion of its levels in the APOE ε3 mice (Fig. 2). Control sham
experiments, in which both mouse groups were similarlyFig. 2. Apolipoprotein (APOE) (A) and ATP-binding cassette transporters A1 (B) l
ε3 and APOE ε4 mice. Representative immunoblots are presented in the lower pane
levels relative to the levels of na€ıve apoE3 mice are shown in the upper panels.*Ptreated except that no stimuli was given, had no effect on
the levels of either apoE or ABCA1 (Fig. 2)
3.2.2. Accumulation of Ab42 and hyperphosphorylated tau
in hippocampal neurons
In accordance with previous histological and enzyme-
linked immunosorbent assay (ELISA) experiments [20],
the levels of intraneuronal Ab42 and hyperphosphorylated
tau (e.g. Monoclonal antibody AT8) in CA3 neurons wereevels in the hippocampus of na€ıve, sham-treated, and fear conditioned APOE
ls. Quantization of the results (mean6 SEM; n5 8–10 per group) and their
, .05. **P , .01.
Fig. 3. Amyloid beta (Ab42) (A) and hyperphosphorylated tau (monoclonal antibody [mAb] AT-8) (B) levels in CA3 neurons of na€ıve, sham-treated, and fear-
conditioned APOE ε3 and APOE ε4 mice. Ab42 and AT-8 immunohistochemistry was performed as described in section 2. Sections stained with either anti-
Ab42 or mAb AT-8 are presented in the lower panels. Quantization of the results (mean6 SEM; n5 8–10 per group) and their levels relative to the levels of
na€ıve APOE ε3 mice are shown in the upper panels. *P , .05.
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with the corresponding APOE ε3mice (Fig. 3). Interestingly,
both of these histological effects were abolished in sham
control-treated mice that were exposed to the same handling
and environmental changes as were the stimulated mice but
without the electrical and tone stimulation, and the associ-
ated learning. In the case of Ab42 the effect was associated
with reduced Ab42 levels in the APOE ε4 mice, rendering
them similar to the apoE3 mice, which were not affected
by this handling (Fig. 3A). However, regarding hyperphos-
phorylated tau (e.g. AT8), this was associated with reduced
hyperphosphorylated tau in the APOE ε4 mice and a smallFig. 4. Doublecortin (DCX) (A) and VGluT (B) levels in hippocampal neurons of n
of DCX in the dentate gyrus and of VGluT in CA3 neurons were determined immu
with either anti-DCX or anti-VGluTare presented in the lower panels. Quantization
the levels of na€ıve apoE3 mice are shown in the upper panels. *P , .05.elevation of hyperphosphorylated tau in the APOE ε3
mice. Importantly, these parameters were not further
affected by exposing the mice to the electrical and tone stim-
uli, and the concurrent learning process (Fig. 3).
3.2.3. Neuronal pathology
Wenext examined the extent towhich exposure to the fear-
conditioning paradigm affects APOE ε4-driven neuronal
pathology. This was first assessed by using DCX, which is a
specific marker of newly formed neurons in the hippocampal
dentate gyrus [37]. The levels of DCX-positive neurons in the
dentate gyrus were found to be higher in na€ıve APOE ε4 thana€ıve, sham-treated, and fear-conditioned apoE3 and apoE4 mice. The levels
nohistochemically, as described in section 2. Representative sections stained
of the results (mean6 SEM; n5 8–10 per group) and their levels relative to
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dancewith previous observations obtained with APOE ε4 and
APOE ε3 transgenic mice [27]. This effect was abolished,
however, by subjecting the mice to sham control treatment
and was not further affected by the electrical and tone stimu-
lations (Fig. 4A). We next measured the effects of the APOE
genotype and behavioral testing on the levels of the presynap-
tic glutamate transporter (VGluT). This revealed that, in
accordance with previous observations [20,23], the levels of
VGluT in CA3 neurons were lower in the APOE ε4 than in
the APOE ε3 mice (Fig. 4B). However, as observed with
DCX, this effect was abolished following exposure of the
mice to control sham treatment and was not further affected
by the electrical and tone stimuli (Fig. 4B).
Taken together, these results indicate that exposure to
behavioral testing, using the fear conditioning paradigm,
results in a marked effect on the phenotypic expression of
the APOE ε4 genotypes. For some parameters, such as
APOE and ABCA1, this is induced by the electrical and
tone stimulations, whereas other APOE ε4-driven pheno-
types (e.g., Ab, tau hyperphosphorylation, and the neuronal
parameters DCX and VGluT) are already affected by sham
treatments of the mice.
3.2.4. Novel object recognition test
These experiments examined the extent to which subject-
ing the mice to the novel object recognition test affects the
brain phenotypic expression of APOE ε3 and APOE ε4. As
shown in Fig. 5A and in accordance with our previous find-
ings [16], the APOE ε3 mice but not the APOE ε4 mice
choose preferentially the novel object. Importantly, and un-
like in the fear-conditioning test, the brain parameters of the
object recognition-tested APOE ε3 and APOE ε4 mice were
not affected by the test and were similar to those of the na€ıve
mice (compare Fig. 5B to Figs. 3 and 4).4. Discussion
This study investigated the extent to which the
exposure of APOE ε4 and APOE ε3 mice to behavioralFig. 5. Apolipoprotein (APOE) ε4 and APOE ε3 object recognition test and its effe
the object recognition test after which the levels of the indicated brain parameters w
by the APOE ε4 and APOE ε3 mice near the novel object to the total time spent nea
of the levels of amyloid beta 42 (Ab42), phosphorylated tau (AT8), and VgluT in
shown represent the mean 6 SEM of n 5 8–10 mice per group. *P , .05 for a cparadigms affects their brain parameters and whether it
modulates the APOE genotype-dependent differences be-
tween these mice. This was pursued by exposing young
APOE ε4-and APOE ε4-targeted replacement mice to
the fear-conditioning and object recognition paradigms
and examining the resulting effects on distinct hippocam-
pal parameters, including the neuronal levels of the AD
hallmarks, Ab42, and hyperphosphorylated tau, the syn-
aptic and neuronal parameters, VGluT and DCX, and
APOE and its lipidation protein, ABCA1. This revealed
that the APOE ε4 mice had impaired contextual memory
and that all the physiological parameters were affected
by the fear-conditioning treatment such that the pheno-
typic differences between APOE ε3 and APOE ε4, which
were apparent in these mice under na€ıve conditions, were
virtually abolished following these treatments. Two types
of effects were thus observed. The first type, which
included Ab42 and AT-8, and DCX and VGluT, was
already caused by the sham treatment, namely, exposure
to the chambers of the fear conditioning paradigm without
administering the shock and the tone, and these treatments
were not further affected by the electrical and tone stim-
ulation or by the concurrent learning process. The finding
that the fear-conditioning experiment has no additional
effect on these parameters may be due to a ceiling effect
or because these parameters are not affected by the elec-
trical and tone stimulation. The second group of parame-
ters included APOE and ABCA1, whose levels were
affected only following the electrical and tone stimula-
tion. In contrast, the object recognition paradigm had no
effect on the corresponding brain parameters of the
APOE ε3 and APOE ε4 mice. Preliminary experiments,
using the Morris Water Maze test, revealed that this test,
which is also associated with stress, also affects the brain
parameters and abolishes the differences between the
APOE ε3 and APOE ε4 mice. These results are in accor-
dance with and extend previous findings that showed that
the exposure of wild-type mice to fear conditioning in-
duces distinct brain effects such as endurable epigenetic
changes [38] and an increase in the phosphorylation ofct on brain parameters. Na€ıve APOE ε4 and APOE ε3 mice were subjected to
ere determined as outlined in section 2. (A) The ratio between the time spent
r both the familiar and novel objects. (B) Immunohistochemical comparison
CA3 and doublecortin in the dentate gyrus hippocampal neurons. Results
omparison of the APOE ε4 and the APOE ε3 groups.
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ential methylation in the brain-derived neurotrophic factor
(BDNF) promoter [40]. The finding that the APOE ε4 and
APOE ε3 mice respond differently to fear-conditioning
testing and that this exposure virtually abolishes the
phenotypic difference between the APOE ε4 and APOE
ε3 mice is of great experimental importance and shows
that the analysis of biochemical markers and behavioral
measurements in the same cohort can mask biochemical
differences that are apparent under na€ıve conditions.
The behavioral experience of the sham-treated mice
involves both handling and exposure to a new environment.
Previous studies showed that the exposure of young na€ıve
wild-type mice to an enriched environment induces brain
biochemical changes [4] and that handling of the mice
induces physiological and biochemical changes in various
systems including the hypothalamic–pituitary–adrenal axis
[41], long-term potentiating [42], and behavioral effects
[43], and various other phenotypes [44]. The extent to which
the presently observed effects of the sham treatment on hip-
pocampal Ab42, AT-8, VGluT, and DCX levels are related to
handling and/or to exposure to a specific environment are not
known. Importantly, the novel object recognition test, which
also includes handling and exposure to a new environment,
induced no differences in the phenotypic expression of the
APOE ε3 and APOE ε4 mice. The mechanisms which spe-
cifically mediate the effects of the fear conditioning sham
treatment but which are not involved in the novel recognition
test remain to be determined. The second group of parame-
ters, which includes APOE and the APOE lipidation protein,
ABCA1, were affected only by the actual fear condition
treatment and not by the sham treatment. These paradigms
involve stress and learning experiences and it is thus possible
that the observed changes in the hippocampal levels of
APOE and ABCA1 are related to stress and/or to learning.
Recent findings suggest that human APOE ε4 carriers are
particularly susceptible to stress [45–47]. Accordingly, the
brain parameters whose levels are affected by the electrical
stimulation, which is clearly stress-related, probably model
a similar stress-related effect in the mouse. However, it re-
mains to be determined whether the brain parameters that
were affected by milder treatments, such as the sham treat-
ment of the fear conditioning experiment, are associated
with a more subtle stress response which is not apparent in
the object recognition test and whether such effects can
also be observed in aged AD patients.
In conclusion, the results thus obtained indicate that the
exposure of APOE ε4- and APOE ε4-targeted replacement
mice to behavioral testing has marked effects on hippocam-
pal, neuronal, and biochemical parameters and that it masks
the phenotypic differences between these mice, which are
apparent under na€ıve conditions. This has important theoret-
ical and practical implications and suggests that the assess-
ment of brain and behavioral parameters should be
performed on different cohorts of mice.Acknowledgments
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1. Systematic review: Apolipoprotein (APOE) ε4 is the
most prevalent genetic risk factor for Alzheimer’s
disease (AD). Experiments with APOE ε3 and
APOE ε4 mouse models involve the pursuit of
biochemical and behavioral measurements that often
use the same cohort of mice. A growing body of ev-
idence suggests that environmental and behavioral
manipulations can greatly affect brain parameters
and physiology. We presently investigated, using tar-
geted replacement mice that express APOE ε4 or
APOE ε3, the extent to which exposure to fear condi-
tioning and object recognition paradigms can affect
key biochemical phenotypes of APOE ε3 and
APOE ε4.
2. Interpretation: The results obtained revealed that
fear conditioning and even sham behavioral treat-
ment has marked effects on the brains of the
APOE ε4 mice and abolishes the phenotypic differ-
ences between the APOE ε3 and APOE ε4 mice. In
contrast, the object recognition test, in which the
behavioral manipulation is milder, did not affect
the APOE ε4 and APOE ε3 brain phenotypes. These
results show that the brains of APOE ε4 mice are
particularly susceptible to changes in the environ-
mental conditions that are associated with cognitive
testing.
3. Future directions: These results point to the need to
include in mouse biochemical and behavioral studies
some measurements of the effects of behavioral
manipulation on the mouse brain. Additionally, the
results show that at least for young mice, behavioral
testing can counteract the APOE ε4 phenotype. The
extent to which the pathological effect of apoE4 in
aged mice, or even in AD, can be counteracted by
similar behavioral treatments is not known and con-
stitutes a promising hypothesis to be investigated in
the future.
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